Hereditary pancreatic cancer [12 genes]
10-15% of pancreatic cancer are due to a predisposition syndrome towards hereditary cancer, such as hereditary breast and ovarian cancer, familial melanoma, Lynch syndrome, familial adenomatous polyposis, Peutz-Jeghers syndrome, or Li-Fraumeni syndrome. The remaining 85-90% do not present a recognizable genetic syndrome and are considered as familial pancreatic cancer (FPC). The recommended genetic study strategy is, therefore, to carry out a differential diagnosis of the main syndromes by sequencing genes like BRCA1, BRCA2, PALB2, CDKN2A, MLH1, MSH2, MSH6, APC, STK11, and TP53, among others.
Steps to follow
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Solicita información de
Hereditary pancreatic cancer
Turnaround time (TAT): 4 weeks
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.